Clinical Trial Update: Mammography SPECT With Rotating Slant Hole Collimator

View source ↗

Summary

A Johns Hopkins University-sponsored clinical trial evaluating Mammography SPECT with a rotating slant-hole collimator for breast cancer has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Johns Hopkins University | Conditions: Breast Cancer | Status: WITHDRAWN